MedTrace Logo

4P: Persistent Postoperative Pediatric Pain

NCT06035042 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2026-01-28

No results posted yet for this study

Summary

For children, adequate perioperative pain management is a right according to the UN convention on the rights of the child, a law in Sweden since 2020. Despite this, children are still under-treated in many cases. In addition to great suffering, this can lead to missing school and a long-term burden on the society.

ESPA, the European Society for Pediatric Anesthesia, has drawn up guidelines for perioperative pain management. With the study 4P: Persistent Postoperative Pediatric Pain, we want to investigate whether these guidelines are followed and how many children develop long-term pain postoperatively.

In order to map the prevalence of pain after surgery in children in Sweden, the investigators plan to include and follow 2000 children in southern Sweden who undergo surgery. The study provides a unique opportunity to follow a large number of children, evaluate given per- and postoperative pain treatment and identify factors linked to the development of acute and long-term postoperative pain. Our goal is to optimize peri- and postoperative pediatric pain management to promote rapid recovery after surgery.

Conditions

  • Postoperative Pain

Interventions

PROCEDURE

Scheduled surgery

All subjects will be exposed to surgery

Sponsors & Collaborators

  • Lund University

    collaborator OTHER

  • Region Skane

    collaborator OTHER

  • Vastra Gotaland Region

    collaborator OTHER_GOV

  • Region Halland

    lead OTHER

Principal Investigators

  • Anna KM Persson, MD, PhD · Region Halland

Eligibility

Min Age
1 Year
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-09-01
Primary Completion
2024-09-28
Completion
2026-01-28

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06035042 on ClinicalTrials.gov